Article
Pharmacokinetic considerations for optimizing inhaled spray-dried pyrazinoic acid formulations
2023-04-03
Abstract excerpt
<h4>ABSTRACT</h4> Tuberculosis (TB), caused by Mycobacterium tuberculosis ( Mtb ), remains a leading cause of death with 1.6 million deaths worldwide reported in 2021. Oral pyrazinamide (PZA) is an integral part of anti-TB regimens, but its prolonged use has the potential to drive development of PZA resistant Mtb . PZA is converted to the active moiety pyrazinoic acid (POA) by the Mtb pyrazinamidase encoded b...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7986f3b7-e1ba-5516-917d-0c4fbfb5f729
- DOI
- 10.1101/2023.04.01.534965
